<3S-(1Z,3α,5β)>-<2-<3-Fluoro-5-<<(1,1-dimethylethyl)dimethylsilyl>oxy>-2-methylenecyclohexylidene>ethyl>diphenylphosphine Oxide | 123836-63-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: <3S-(1Z,3α,5β)>-<2-<3-Fluoro-5-<<(1,1-dimethylethyl)dimethylsilyl>oxy>-2-methylenecyclohexylidene>ethyl>diphenylphosphine Oxide
• 英文别名: [3S-(1Z,3α,5β)]-[2-[3-fluoro-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-2-methylenecyclohexylidene]ethyl]diphenylphosphine oxide；[(2Z)-2-[(3S,5R)-5-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3-fluoro-2-methylenecyclohexylidene]-ethyl]diphenylphosphine oxide；(15,5R)-1-((tert-butyldimethyl)silanyloxy)-3-[2-(diphenylphosphinoyl)-eth-(Z)-ylidene]-5-fluoro-2-methylene-cyclohexane；(1S,5R)-1-((tert-butyldimethyl)silanyloxy)-3-[2-(diphenylphosphinoyl)-eth-(Z)-ylidene]-5-fluoro-2-methylene-cyclohexane；(1S,5R)-1-((tert-butyldimethyl)silanyloxy)-3-[2-(diphenylfosphinoyl)-eth-(Z)-ylidene]-5-fluoro-2-methylene-cyclohexane；(1S,3Z,5R)-1-fluoro-5-((t-butyldimethyl)silanyloxy)-2-methenyl-3-(diphenylphosphinoyl)ethylidene cyclohexane；tert-butyl-[(1R,3Z,5S)-3-(2-diphenylphosphorylethylidene)-5-fluoro-4-methylidenecyclohexyl]oxy-dimethylsilane
• CAS: 123836-63-5
• 化学式: C₂₇H₃₆FO₂PSi
• 分子量: 470.639
• InChiKey: IGIUNYVEBAUZSE-LQBLIBPBSA-N

物化性质

• 沸点：
  509.1±50.0 °C(Predicted)
• 密度：
  1.07±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  7.01
• 重原子数：
  32
• 可旋转键数：
  7
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.41
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  <3S-(1Z,3α,5β)>-<2-<3-Fluoro-5-<<(1,1-dimethylethyl)dimethylsilyl>oxy>-2-methylenecyclohexylidene>ethyl>diphenylphosphine Oxide 在 正丁基锂 、 四丁基氟化铵 作用下， 以 四氢呋喃 为溶剂， 反应 20.1h， 生成 1α-Fluoro-25-hydroxyergocalciferol
  参考文献：
  名称：

  Total synthesis of 1.alpha.-fluoro-25-hydroxycholecalciferol and -ergocalciferol

  摘要：

  DOI：

  10.1021/jo00288a040
• 作为产物：
  描述：

  (2R,3S,7S)-[7-((t-butyldimethyl)silanyloxy)-4-methylene-1-oxa-spiro[2.5]oct-2-yl]-methanol 在 吡啶 、 叔丁基过氧化氢 、 selenium(IV) oxide 、 三光气 、 二乙胺基三氟化硫 、 sodium methylate 、 sodium hydride 、 三苯基膦 作用下， 以 1,4-二氧六环 、 吡啶 、 甲醇 、 正壬烷 、 正己烷 、 三氯乙烯 、 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 50.33h， 生成 <3S-(1Z,3α,5β)>-<2-<3-Fluoro-5-<<(1,1-dimethylethyl)dimethylsilyl>oxy>-2-methylenecyclohexylidene>ethyl>diphenylphosphine Oxide
  参考文献：
  名称：

  WO2007/110109

  摘要：

  公开号：

文献信息

• [EN] VITAMIN D ANALOGUES, COMPOSITIONS COMPRISING SAID ANALOGUES AND THEIR USE<br/>[FR] ANALOGUES DE LA VITAMINE D, COMPOSITIONS COMPRENANT LESDITS ANALOGUES ET LEUR UTILISATION
  申请人：LEO PHARMA AS

  公开号：WO2004037781A1

  公开（公告）日：2004-05-06

  Compounds according to formula I: in which formula R1 and R2, which may be the same or different, represent halogen, (C1-C6) hydrocarbyl, optionally substituted with one or two hydroxyl group on one or more fluorine atoms, or, together with the carbon atom to which they are both attached, R1 and R2 form a (C3-C6)carbocyclic ring, or one of R1 and R2 taken together with R3 forms a direct bond, such that a triple bond is constituted, or R1 and R2 represent both hydrogen; R3 when not forming a direct bond with one of R1 and R2 represents hydrogen or (C1-C3)hydrocarbyl; X represents (E)-ethylene, (Z)-ethylene, ethynylene, or a bond; Y and Z independently represent hydrogen or methyl; the bond between C#16 and C#17 is depicted with a dotted line to illustrate that said bond may be either a single bond, in which case the projection of the ring substituents is beta, or a double bond; A represents hydroxyl, fluorine or hydrogen; B represents CH2 or H2; the configuration is the 3-position corresponds to the same configuration as in natural vitamine D3 (normal), or the configuration in the configuration in the 3-position is opposite to that of natural vitamin D3(epi); with the proviso that when X represents (E)-ethylene or (Z)-ethylene, one of R1 and R2 taken together with R3 may not form a direct bond, such that a triple bond is constituted; with the further proviso that when X represents a bond R1 ands R2 are nor hydrogen; with the further proviso that the compound of formula I is not 3(S)-hyroxy-9, 10-secocholesta-5(Z),7(E),10(19),22(E),24-penta-ene; and prodrugs and stereo isomeric forms thereof are provided together with their use in therapy, and their use in the manufacture of medicaments.

  根据公式I：其中公式中的R1和R2，可以相同也可以不同，代表卤素，(C1-C6)烃基，可选地在一个或多个氟原子上用一个或两个羟基取代，或者，与它们都连接的碳原子一起，R1和R2形成一个(C3-C6)碳环，或者R1和R2中的一个与R3一起形成直接键，从而构成三键，或者R1和R2都代表氢；当R3不与R1和R2中的一个形成直接键时，代表氢或(C1-C3)烃基；X代表(E)-乙烯，(Z)-乙烯，乙炔基，或者一个键；Y和Z独立地代表氢或甲基；C#16和C#17之间的键用虚线表示，以说明该键可以是单键，此时环取代基的投影为β，或者是双键；A代表羟基，氟或氢；B代表CH2或H2；3位的构型与天然维生素D3 (正常)中的构型相对应，或者3位的构型与天然维生素D3 (epi)中的构型相反；但是当X代表(E)-乙烯或(Z)-乙烯时，R1和R2中的一个与R3一起不能形成直接键，从而构成三键；进一步的条件是，当X代表一个键时，R1和R2不是氢；进一步的条件是，公式I的化合物不是3(S)-羟基-9,10-去甲胆骨化甾-5(Z),7(E),10(19),22(E),24-五烯；还提供了它们的前药和立体异构体形式，以及它们在治疗中的用途，以及它们在药物制造中的用途。
• [EN] USE OF VITAMIN D COMPOUNDS FOR THE PREVENTION OR TREATMENT OF CHRONIC PROSTATITIS<br/>[FR] UTILISATION DE COMPOSES DE VITAMINE D POUR LA PREVENTION OU LE TRAITEMENT DE LA PROSTATITE CHRONIQUE
  申请人：BIOXELL SPA

  公开号：WO2006035075A1

  公开（公告）日：2006-04-06

  The use of a vitamin D compound in the prevention or treatment of chronic prostatitis and related methods, pharmaceutical formulations and kits.

  维生素D化合物在慢性前列腺炎的预防或治疗中的使用，以及相关方法、药物配方和工具包。
• Efficient Synthesis of 1α-Fluoro A-Ring Phosphine Oxide, a Useful Building Block for Vitamin D Analogues, from (<i>S</i>)<i>-</i>Carvone via a Highly Selective Palladium-Catalyzed Isomerization of Dieneoxide to Dieneol
  作者：Marek M. Kabat、Lisa M. Garofalo、Andrzej R. Daniewski、Stanley D. Hutchings、Wen Liu、Masami Okabe、Roumen Radinov、Yuefen Zhou

  DOI：10.1021/jo015788y

  日期：2001.9.1

  block for fluorinated vitamin D analogues, was synthesized from (S)-carvone in 13 synthetic steps, and only five isolations, in 22% overall yield. In the key synthetic step, a highly selective palladium-catalyzed isomerization of dieneoxide 18 to dieneol 20 was achieved using an appropriately selected fluorinated alcohol as a catalytic proton source.

  由（S）-香芹酮经13个合成步骤合成了1alpha-氟A环氧化膦1（一种有用的氟化维生素D类似物的结构单元），仅进行了5次分离，总收率为22％。在密钥合成步骤，使用适当选择的氟化醇作为催化质子源达到dieneoxide 18的高度选择性钯催化异构化为dieneol 20。
• IMPROVED PREPARATION OF A-RING PHOSPHINE OXIDES FOR THE SYNTHESIS OF VITAMIN D ANALOGS
  作者：Andrzej R. Daniewski、Lisa M. Garofalo、Marek M. Kabat

  DOI：10.1081/scc-120012994

  日期：2002.1

  ABSTRACT A new, high yielding, two-step process for the preparation of A-ring phospine oxides from allyl alcohols, useful for the synthesis of vitamin D analog, is described, in which triphosgene and diphenylphosphine oxide are used for chlorination and subsequent substitution reactions, respectively.

  摘要描述了一种新的、高产的、两步法，用于从烯丙醇制备 A 环氧化膦，可用于合成维生素 D 类似物，其中三光气和二苯基氧化膦用于氯化和随后的取代反应， 分别。
• WO2007/22433
  申请人：——

  公开号：——

  公开（公告）日：——